Paper58255
Metabolic fate of administered 1,25-dihydroxycholecalciferol in controls and in patients with hypoparathyroidism.
Mawer EB and 4 others. Lancet, 1976. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Metabolic fate of administered 1,25-dihydroxycholecalciferol in controls and in patients with hypoparathyroidism. Papers, record 58255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metabolic fate of administered 1,25-dihydroxycholecalciferol in controls and in patients with hypoparathyroidism.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dihydroxycholecalciferols | Major topic |
| Hydroxycholecalciferols | Major topic |
| Hypoparathyroidism | Major topic |
| Administration, Oral | |
| Biotransformation | |
| Half-Life | |
| Humans | |
| Hypocalcemia | |
| Injections, Intravenous | |
| Isotope Labeling | |
| Metabolic Clearance Rate | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41599655 | Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41599655 | PubMed |
| 7419714 | Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7419714 | PubMed |
| 6894454 | Vitamin D plasma binding protein. Turnover and fate in the rabbit. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6894454 | PubMed |
| 3930030 | Effects of 1,25 dihydroxyvitamin D3 administration on circadian mineral rhythms in humans. | Calcif Tissue Int | 1985 | https://conductscience.org/library/papers/3930030 | PubMed |
| 3153059 | Vitamin D metabolite profiles in moderate renal insufficiency of childhood. | Pediatr Nephrol | 1988 | https://conductscience.org/library/papers/3153059 | PubMed |
| 912592 | Effects of 1,25-dihydroxycholecalciferol on calcium and phosphorus metabolism in hypoparathyroidism. | Calcif Tissue Res | 1977 | https://conductscience.org/library/papers/912592 | PubMed |
| 908759 | Kinetic analysis of 25-hydroxyvitamin D3 metabolism in strontium-induced rickets in the chick. | J Clin Invest | 1977 | https://conductscience.org/library/papers/908759 | PubMed |
| 647302 | Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? | Br Med J | 1978 | https://conductscience.org/library/papers/647302 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/58255
GET https://conductscience.org/api/papers/v1/58255/authors